Philips North America LLC v. Probo Medical, LLC

District Court, S.D. West Virginia·Decided December 19, 2022·No. 2:21-cv-00298·Unknown

Opinion

UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF WEST VIRGINIA

CHARLESTON DIVISION

PHILIPS NORTH AMERICA LLC,

Plaintiff,

v. Civil Action No. 2:21-cv-00298

PROBO MEDICAL LLC,

Defendant.

ORDER

This matter is before the undersigned on the parties’ opposing “Motion for Protective Order,” filed by Defendant Probo Medical, LLC (“Defendant” or “Probo”), and “Motion to Compel,” filed by Plaintiff Philips North America LLC (“Plaintiff” or “Philips”). (ECF Nos. 85; 91.) Each party’s motion concerns the same central dispute regarding the proper scope of discovery in this matter. On November 15, 2022, the parties appeared, by counsel, for oral argument on the pending motions. The motions were held in abeyance for a short time following the hearing to permit the parties an opportunity to either reach a compromise on their discovery dispute or, if not possible, to narrow their areas of disagreement to the greatest possible extent. (ECF No. 120.) However, the parties advised in their December 8, 2022 Joint Status Report Regarding Discovery Dispute (ECF No. 126) that they continue to be unable to reach an agreement; accordingly, the undersigned finds that both motions are now ripe for adjudication. Having considered the written materials and the arguments, each motion is GRANTED IN PART and DENIED IN PART, as set forth below. I. Background Plaintiff Philips North America LLC (“Philips”) develops, sells, and services medical imaging systems, including ultrasound machines. (ECF No. 80, at 1.) Some features of these machines are not standard—instead, the software options desired by the customer are licensed directly to them by Philips for an additional price. See id. For each

of the Philips machines, only authorized Philips employees can enable the non-standard software options, only the non-standard software options purchased for that specific system are enabled, and only specific, authorized end-users of the machine—who are subject to non-disclosure agreements—can access the non-standard software options. Id. at 1-2. According to Philips, it has made considerable investments in its proprietary software and has gone to these significant measures to limit an end-user who has not paid for the non-standard features from accessing them, because they are confidential trade secrets from which Philips derives economic value from the information being inaccessible to unauthorized customers and Philips’s competitors. Philips alleges that during its investigation of third party medical device repair company, 626 Holdings, LLC and its principal, Alexander Kalish, Philips discovered that

Radon Medical, LLC purchased a custom laptop from Kalish that would allow Radon to access these proprietary features without a license to do so. Philips alleges that the remaining Defendant—Probo Medical, LLC (“Probo”)—obtained this stolen information from Radon in order to gain access to the premium features on the Philips imaging machines without paying Philips for a license to do so and without Philips’s consent. Philips also alleges it recently discovered that two ultrasound machines purchased by King’s Daughters Medical Center (“KDMC”) in Ashland, Kentucky, had a multitude of software options enabled without Philips’s authorization, which it values at over $300,000. (ECF No. 80 at 2.) Philips’s Amended Complaint alleged that in concert with Probo, several entities, including Radon Medical Imaging Corporation-WV, Radon Medical, LLC, and Ultrasound Online LLC—medical-device wholesalers and suppliers that make up the supply chain of the machines from Philips to KDMC—improperly hacked and enabled non-standard software options on the two ultrasound machines. Id. at 2.

Philips claims that Defendants improperly enabled these software features so they could sell Philips’s proprietary software to their customers at a discount and compete directly with Philips for commercial gain. Id. Philips states that the purpose of this lawsuit is “to identify the party, or parties, responsible for the hacking.” Id. Philips also suspects that Probo, through a network of related companies, has used other hacking tools to carry out the same enterprise on a larger scale. Specifically Philips alleges as follows: Probo is engaged in a pattern and practice of purchasing and selling systems that it knows and/or reasonably should know have been modified without authorization from Philips. Over the past several years, Probo has acquired and/or purchased the assets from companies engaged in similar services and business activities, which Probo knows use hacking tools and other methods to unlawfully gain access to Philips’ proprietary tools and to enable unlicensed options on Philips systems. Those companies include, without limitation, KPI Healthcare Inc. . . . . Upon information and belief, Probo directs, authorizes and/or otherwise approves the unlawful methods used by its subsidiaries on the Philips systems it acquires in these transactions.

(ECF No. 28 at 12 ¶ 52.) Based upon these allegations, Philips brings the following against Probo: violation of the Computer Fraud and Abuse Act, 18 U.S.C. § 1030 (“Count I”); violation of the West Virginia Computer Crime and Abuse Act, W. Va. Code § 61-3C-1 et seq. (“Count II”); violation of the Digital Millennium Copyright Act, 17 U.S.C. §§ 1201 and 1202 (“Count III”); violation of the Defendant Trade Secrets Act, 18 U.S.C. § 1836 (“Count IV”); violation of the West Virginia Uniform Trade Secrets Act, W. Va. Code § 47-22-9, et seq. (“Count V”); and Unfair Competition (“Count VI”). (ECF No. 28.) Probo’s Motion for Protective Order accuses Philips of serving “fishing-expedition” discovery, and asks the Court to limit Philips’s written discovery requests to information about the two KDMC machines specifically identified in the Complaint and arguing that

anything more than that is disproportional to the needs of the case. Philips’s Motion to Compel seeks the opposite: Probo’s full compliance with its written discovery requests. II. Legal Standards

Rule 26(b) of the Federal Rules of Civil Procedure provides that “[p]arties may obtain discovery regarding any nonprivileged matter that is relevant to any party's claim or defense and proportional to the needs of the case . . . .” Fed. R. Civ. P. 26(b)(1). “[I]t remains true that “relevancy in discovery is broader than relevancy for purposes of admissibility at trial.” Scott Hutchison Enters., Inc. v. Cranberry Pipeline Corp., 3:15- CV-13415, 2016 WL 5219633, at *2 (S.D.W. Va. Sept. 20, 2016) (citing Amick v. Ohio Power Co., 2:13-cv-6593, 2013 WL 6670238, at *1 (S.D. W. Va. Dec. 18, 2013)). Moreover, “notwithstanding Rule 26(b)(1)’s recent amendment placing an emphasis on the proportionality of discovery, the discovery rules, including Rule 26, remain subject to a ‘broad and liberal construction.’” Scott Hutchison Enters., Inc., 2016 WL 5219633, at *2 (citing Eramo v. Rolling Stone LLC, 314 F.R.D. 205, 209 (W.D. Va. Jan. 25, 2016)). Nonetheless, simply because information is discoverable under Rule 26, “does not mean that discovery must be had.” Scott Hutchison Enters., Inc., 2016 WL 5219633, at *2.

Free access — add to your briefcase to read the full text and ask questions with AI

Philips North America LLC v. Probo Medical, LLC, (S.D.W. Va. 2022).

Philips North America LLC v. Probo Medical, LLC (Philips North America LLC v. Probo Medical, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Cuomo v. Clearing House Ass'n, LLC
557 U.S. 519 (Supreme Court, 2009)
Robert Johnson v. American Towers, LLC
781 F.3d 693 (Fourth Circuit, 2015)
Vica Coal Co. v. Crosby
212 F.R.D. 498 (S.D. West Virginia, 2003)
Collens v. City of New York
222 F.R.D. 249 (S.D. New York, 2004)
Eramo v. Rolling Stone LLC
314 F.R.D. 205 (W.D. Virginia, 2016)
Larouche v. National Broadcasting Co.
780 F.2d 1134 (Fourth Circuit, 1986)